CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyax Corp. (Nasdaq: DYAX) and the Division of Molecular and Health Technologies of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national scientific research agency, announced today that they have entered into a collaboration for the discovery and development of therapeutic antibodies to treat cancer.
